Remove keyword kidney-disease
article thumbnail

Grand Rounds Ethics and Regulatory Series February 10, 2023: Informing and Consenting: What Are the Goals? (P. Pearl O’Rourke, MD; David S. Wendler, PhD, MA; Miguel Vazquez, MD; P. Michael Ho, MD, PhD)

Rethinking Clinical Trials

ICD-Pieces studied patients with chronic kidney disease (CKD), diabetes and hypertension. If you are notifying, when do you offer an opt-out option and what do you do when potential subjects have questions or do not want to be in the research? The intervention was to facilitate delivery of guideline-based care.

article thumbnail

Grand Rounds September 16, 2022: Using Nationwide Registries to Conduct Pragmatic Randomized Trials: The DANFLU Program (Tor Biering-Sørensen, MD, PhD, MPH)

Rethinking Clinical Trials

The DECODE trial used registry data to identify patients with chronic kidney disease. You can always use the system to identify potential candidates and then guide them to the local cardiology, kidney department. Faculty of Health and Medical Sciences. University of Copenhagen. Department of Cardiology. Key Points.

Trials 130